OR WAIT null SECS
March 08, 2021
Upcoming study reveals challenges faced by Europe over the pricing of pharmaceuticals.
March 04, 2021
Pamela D. Garzone, Chief Medical Officer at Calibr, shares her perspectives on how investor decisions are shifting dramatically into biopharmaceuticals.
March 01, 2021
Vaccine manufacturers anticipate significant boosts in output in the coming weeks.
February 25, 2021
The latest initiative against COVID, the European Health Emergency Preparedness and Response Authority, is taking shape with intentions of revealing the vulnerabilities in global supply chains and more.
February 19, 2021
FDA issues a sharp warning letter rebuking AcelRx Pharmaceuticals for its ”glib and simplistic” messaging on painkiller Dsuvia.
February 16, 2021
After three years, member states of the EU have yet to make any real progress on legislation that would coordinate their clinical assessments more closely.
Jane Myles, Director of Decentralized Trials at Covance by LabCorp, and former Head, Operational Intelligence and Innovation at Roche, discusses her journey as a clinical trial participant.
February 15, 2021
Despite challenges and disruptions posed by the coronavirus pandemic this past year, FDA annual reports on drug regulatory programs and policies confirm successful efforts for meeting review time frames and updating policies and programs.
February 12, 2021
Jessica Lee, SVP Clinical Operations and Global Integration at Inovio Pharmaceuticals discusses her perspective on the emergence of novel COVID variants and how they could impact results for sponsors currently running COVID-19 studies
R&D on medical treatments lags notable success with vaccines.